Sort
15,273 grants matching “antimicrobial resistance”
Radical SAM-dependent methylation in antibiotic resistance
$526,822Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2023 · AI
Training Innate Immunity: A new approach to the treatment of Sepsis
$526,721David L. Williams · East Tennessee State University · R01 · FY2024 · GM
Training Innate Immunity: A new approach to the treatment of Sepsis
$526,721David L. Williams · East Tennessee State University · R01 · FY2023 · GM
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$526,238Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$526,238Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Broad spectrum Shigella subunit vaccine based on conserved proteins
$526,163Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2024 · AI
Evolution and acquistion of drug resistance in MRSA
$525,863Alexander Tomasz · Rockefeller University · R01 · FY2008 · AI
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
$525,544Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
REGULATION OF CELL DIVISION
$525,537Joseph F Lutkenhaus · University Of Kansas Medical Center · R37 · FY2009 · GM
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$525,483Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
DUE TO THE SIGNIFICANCE IN ANIMAL AND PUBLIC HEALTH, ADDRESSING ANTIMICROBIAL RESISTANCE IS THE RESPONSIBILITY OF ALL, INCLUDING MEDICAL AND VETERINARY PROFESSIONALS AND THE GENERAL PUBLIC. AN IMPORTANT PREREQUISITE TO MITIGATION OF AMR IS UNDERSTANDING THE BURDEN IN EACH OF THE POTENTIAL RESERVOIRS OF AMR IN THE ENVIRONMENT. DESPITE THE FACT THAT ANTIBIOTICS ARE USED INSMALL RUMINANT AGROSYSTEMS, ALBEIT IN AN EXTRA-LABEL MANNER, NO STUDIES HAVE EVALUATED THE POTENTIAL EXISTENCE OF AMR IN THESE SYSTEMS. BESIDES, SMALL RUMINANTS ARE HOSTS TO BACTERIA INCLUDING E.COLI, SALMONELLA, AND CAMPYLOBACTER OF PUBLIC HEALTH IMPORTANCE THAT MAY BE RESISTANT TO ANTIBIOTICS MAKING IT DIFFICULT TO TREAT THESE CONDITIONS. THUS AN UNDERSTANDING OF THE EXTENT OF ANTIMICROBIAL RESISTANCE IN THESE SYSTEMS AND FACTORS THAT LEAD TO THE USE OF ANTIBIOTICS WILL BE USEFUL IN DESIGNING EDUCATIONAL TOOLS TO CREATE AWARENESS AND PROVIDE RESOURCES TO ADDRESS AMR IN THESE SYSTEMS.IN THIS PROJECT, SMALL RUMINANT FARMS WILL BE VISITED AND FECAL SAMPLES WILL BE COLLECTED FROM SMALL RUMINANTS. ADDITIONALLY, ABATTOIRS, STATE FAIRS, AND LIVESTOCK AUCTION SITES WILL BE VISITED AND FECAL SAMPLES COLLECTED FROM SMALL RUMINANTS ON SITE. IN THE LABORATORY, SAMPLES WILL BE SCREENED FOR THE PRESENCE OF BACTERIA THAT ARE RESISTANT TO IMPORTANT ANTIBIOTICS. PRODUCERS WILL ALSO FILL OUT A SURVEY ON ANTIBIOTIC USE ON THEIR FARMS. DATA COLLECTED FROM THE LABORATORY WILL INFORM ON HOW COMMON ANTIBIOTIC-RESISTANT BACTERIA ARE IN SMALL RUMINANTS, WHICH TYPE OF ANTIBIOTICS MOST ARE RESISTANT TO, AND IF THE TYPE OF RESISTANCE CAN BE SPREAD TO OTHER BACTERIA IN THE ANIMAL, ENVIRONMENT, AND HUMANS. IN ADDITION, WE SHALL HAVE AN UNDERSTANDING OF WHAT FACTORS OR CHALLENGES SMALL RUMINANT PRODUCERS FACE, THAT LEAD TO THE USE OF ANTIBIOTICS ON THE FARM.THIS INFORMATION COMBINED WILL INFORM AND BE USED TO REACH OUT TO SMALL RUMINANT CLIENTELE THROUGH EDUCATIONAL WORKSHOPS, TO CREATE AWARENESS ON THE SIGNIFICANCE OF AMR TO BUILDCONNECTIONSAND GENERATE RESOURCES TO HELP THEM ADDRESS ANIMAL HEALTH CHALLENGES, AND TO REDUCE OR PREVENT AMR IN THESE SYSTEMS.
$525,472Virginia State University · · FY2022 · National Institute of Food and Agriculture
Plasma Protein Biomarker-Based Diagnostics Of Outcome I*
$525,103Stephen Francis Kingsmore · National Center For Genome Resources · U01 · FY2006 · AI
Bacillus Anthracis
$525,006Mark R Deziel · Ordway Research Institute, Inc. · P01 · FY2009 · AI
Mechanisms of the M protein in group A Streptococcus virulence
$524,859Partho Ghosh · University Of California, San Diego · R01 · FY2012 · AI
Flagellin-induced gut epithelial chemokine secretion
$524,750Andrew T Gewirtz · Emory University · R01 · FY2009 · DK
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$524,705Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Bacterial RNAP sigma factor structure and function
$524,654Seth A Darst · Rockefeller University · R01 · FY2012 · GM
Nonthrombogenic, Antiseptic Nitric Oxide Releasing Catheters
$524,620Scott I Merz · Mc3, Inc. · R44 · FY2016 · HL
Uncultured bacteria for the discovery of novel antimicrobials
$524,361Amy Lynn Spoering · Northeastern University · P01 · FY2016 · AI
Precision targeting of T cell cytotoxicity with PET
$524,205Michael John Evans · University Of California, San Francisco · R01 · FY2021 · CA
The role of CD40L in resistance to enteric infection
$524,066Christopher A Hunter · University Of Pennsylvania · U01 · FY2025 · AI
Bacterial Genomic Diversity
$524,002Maynard V. Olson · University Of Washington · U54 · FY2009 · AI
RUI: Benzoate and pH Stress in Experimental Evolution of Escherichia coli
$524,000Joan L Slonczewski · Kenyon College · · FY2016 · BIO
The Gonococcal Fur Regulon Link to Pathogenesis
$523,824Caroline A Genco · Tufts University Boston · R01 · FY2017 · AI
Novel Applications of Mass Spectrometry and Proteomics to Infectious Disease Diagnostics
$523,803John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI